Can we contain the COVID-19 outbreak with the same measures as for SARS?

Annelies Wilder-Smith, Calvin J Chiew, Vernon J Lee, Annelies Wilder-Smith, Calvin J Chiew, Vernon J Lee

Abstract

The severe acute respiratory syndrome (SARS) outbreak in 2003 resulted in more than 8000 cases and 800 deaths. SARS was eventually contained by means of syndromic surveillance, prompt isolation of patients, strict enforcement of quarantine of all contacts, and in some areas top-down enforcement of community quarantine. By interrupting all human-to-human transmission, SARS was effectively eradicated. By contrast, by Feb 28, 2020, within a matter of 2 months since the beginning of the outbreak of coronavirus disease 2019 (COVID-19), more than 82 000 confirmed cases of COVID-19 have been reported with more than 2800 deaths. Although there are striking similarities between SARS and COVID-19, the differences in the virus characteristics will ultimately determine whether the same measures for SARS will also be successful for COVID-19. COVID-19 differs from SARS in terms of infectious period, transmissibility, clinical severity, and extent of community spread. Even if traditional public health measures are not able to fully contain the outbreak of COVID-19, they will still be effective in reducing peak incidence and global deaths. Exportations to other countries need not result in rapid large-scale outbreaks, if countries have the political will to rapidly implement countermeasures.

Copyright © 2020 Elsevier Ltd. All rights reserved.

References

    1. Chan JF, Kok KH, Zhu Z, et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect. 2020;9:221–236.
    1. Jia HP, Look DC, Shi L, et al. ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia. J Virol. 2005;79:14614–14621.
    1. Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382:727–733.
    1. Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020 doi: 10.1056/NEJMoa2001316. published online Jan 29.
    1. Lipsitch M, Cohen T, Cooper B, et al. Transmission dynamics and control of severe acute respiratory syndrome. Science. 2003;300:1966–1970.
    1. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506.
    1. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507–513.
    1. Holshue ML, DeBolt C, Lindquist S, et al. First case of 2019 novel coronavirus in the United States. N Engl J Med. 2020 doi: 10.1056/NEJMoa2001191. published online Jan 31.
    1. Pan F, Ye T, Sun P, et al. Time course of lung changes on chest CT during recovery from 2019 novel coronavirus (COVID-19) pneumonia. Radiology. 2020 doi: 10.1148/radiol.2020200370. published online Feb 13.
    1. Wilder-Smith A, Freedman DO. Isolation, quarantine, social distancing and community containment: pivotal role for old-style public health measures in the novel coronavirus (2019-nCoV) outbreak. J Travel Med. 2020 doi: 10.1093/jtm/taaa020. published online Feb 13.
    1. Cetron M, Simone P. Battling 21st-century scourges with a 14th-century toolbox. Emerg Infect Dis. 2004;10:2053–2054.
    1. Cheng PK, Wong DA, Tong LK, et al. Viral shedding patterns of coronavirus in patients with probable severe acute respiratory syndrome. Lancet. 2004;363:1699–1700.
    1. Li Y, Yu IT, Xu P, et al. Predicting super spreading events during the 2003 severe acute respiratory syndrome epidemics in Hong Kong and Singapore. Am J Epidemiol. 2004;160:719–728.
    1. Gumel AB, Ruan S, Day T, et al. Modelling strategies for controlling SARS outbreaks. Proc Biol Sci. 2004;271:2223–2232.
    1. Wilson-Clark SD, Deeks SL, Gournis E, et al. Household transmission of SARS, 2003. CMAJ. 2006;175:1219–1223.
    1. Goh KT, Cutter J, Heng BH, et al. Epidemiology and control of SARS in Singapore. Ann Acad Med Singapore. 2006;35:301–316.
    1. Wilder-Smith A, Green JA, Paton NI. Hospitalized patients with bacterial infections: a potential focus of SARS transmission during an outbreak. Epidemiol Infect. 2004;132:407–408.
    1. Cetron M, Landwirth J. Public health and ethical considerations in planning for quarantine. Yale J Biol Med. 2005;78:329–334.
    1. Svoboda T, Henry B, Shulman L, et al. Public health measures to control the spread of the severe acute respiratory syndrome during the outbreak in Toronto. N Engl J Med. 2004;350:2352–2361.
    1. Tsang T, Lam TH. SARS: public health measures in Hong Kong. Respirology. 2003;8:S46–S48.
    1. Ahmad A, Krumkamp R, Reintjes R. Controlling SARS: a review on China's response compared with other SARS-affected countries. Trop Med Int Health. 2009;14:36–45.
    1. de Vlas SJ, Feng D, Cooper BS, Fang LQ, Cao WC, Richardus JH. The impact of public health control measures during the SARS epidemic in mainland China. Trop Med Int Health. 2009;14:101–104.
    1. Leung GM, Quah S, Ho LM, et al. A tale of two cities: community psychobehavioral surveillance and related impact on outbreak control in Hong Kong and Singapore during the severe acute respiratory syndrome epidemic. Infect Control Hosp Epidemiol. 2004;25:1033–1041.
    1. Leung GM, Hedley AJ, Ho LM, et al. The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients. Ann Intern Med. 2004;141:662–673.
    1. McDonald LC, Simor AE, Su IJ, et al. SARS in healthcare facilities, Toronto and Taiwan. Emerg Infect Dis. 2004;10:777–781.
    1. Tan CC. SARS in Singapore—key lessons from an epidemic. Ann Acad Med Singapore. 2006;35:345–349.
    1. Wilder-Smith A, Paton NI, Goh KT. Experience of severe acute respiratory syndrome in Singapore: importation of cases, and defense strategies at the airport. J Travel Med. 2003;10:259–262.
    1. Wilder-Smith A. The severe acute respiratory syndrome: impact on travel and tourism. Travel Med Infect Dis. 2006;4:53–60.
    1. McCloskey B, Heymann DL. SARS to novel coronavirus—old lessons and new lessons. Epidemiol Infect. 2020;148:e22.
    1. Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet. 2020;395:470–473.
    1. Nkengasong J. China's response to a novel coronavirus stands in stark contrast to the 2002 SARS outbreak response. Nat Med. 2020 doi: 10.1038/s41591-020-0771-1. published online Jan 27.
    1. Wilson ME, Chen LH. Travelers give wings to novel coronavirus (2019-nCoV) J Travel Med. 2020 doi: 10.1093/jtm/taaa015. published online Feb 3.
    1. Bogoch II, Watts A, Thomas-Bachli A, et al. Potential for global spread of a novel coronavirus from China. J Travel Med. 2020 doi: 10.1093/jtm/taaa011. published online Jan 27.
    1. Bogoch II, Watts A, Thomas-Bachli A, Huber C, Kraemer MUG, Khan K. Pneumonia of unknown etiology in Wuhan, China: potential for international spread via commercial air travel. J Travel Med. 2020 doi: 10.1093/jtm/taaa008. published online Jan 14.
    1. Wilder-Smith A, Teleman MD, Heng BH, Earnest A, Ling AE, Leo YS. Asymptomatic SARS coronavirus infection among healthcare workers, Singapore. Emerg Infect Dis. 2005;11:1142–1145.
    1. Rothe C, Schunk M, Sothmann P, et al. Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. N Engl J Med. 2020 doi: 10.1056/NEJMc2001468. published online Jan 30.
    1. Phan LT, Nguyen TV, Luong QC, et al. Importation and human-to-human transmission of a novel coronavirus in Vietnam. N Engl J Med. 2020 doi: 10.1056/NEJMc2001272. published online Jan 28.
    1. Quilty BJ, Clifford S, Flasche S, et al. Effectiveness of airport screening at detecting travellers infected with novel coronavirus (2019-nCoV) Euro Surveill. 2020;25
    1. Liu Y, Gayle AA, Wilder-Smith A, Rocklöv J. The reproductive number of COVID-19 is higher compared to SARS coronavirus. J Travel Med. 2020 doi: 10.1093/jtm/taaa021. published online Feb 13.
    1. Rocklöv J, Sjödin H, Wilder-Smith A. COVID-19 outbreak on the Diamond Princess cruise ship: estimating the epidemic potential and effectiveness of public health countermeasures. J Travel Med. 2020 doi: 10.1093/jtm/taaa030. published online Feb 28.
    1. The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19)—China, 2020. China CDC Weekly 2020.

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する